The company
Twist Bioscience Corporation
TWST · Nasdaq
TWST stood above a rising 150-day average in 42 of the last 52 weekly readings, including each of the last 42 weeks. It is 46.4% above that average now. Genomics & Gene Editing: 20% of its 5 stocks in an uptrend (−40 points in four weeks); Health Care: 28% (−9 points in four weeks).
Statistics
- Rotation
- Leading
- Weeks in an uptrend
- 42 in a row
- Industry in uptrend
- 20% -40 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $274.7M
- Officials’ trades on record
- 3
- Institutions holding
- 315 (+51)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 42 of 52 weeks.
Genomics & Gene Editing: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
3 disclosed lines: House 2, Senate 0, executive 1; 2 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Arjun Mody Executive branch: Office of Government EthicsSocial Security Administration | sold | $1k–$15k | 30 Jan 2026filed 10 Apr 2026 |
| Dwight Evans House: U.S. House ClerkPA03 | sold | $1k–$15k | 30 Mar 2022filed 25 Apr 2022 |
| Dwight Evans House: U.S. House ClerkPA03 | bought | $1k–$15k | 2 Mar 2020filed 23 Apr 2020 |
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Adam LaponisChief Financial Officer | sold | 2,462at $156.30 | 9 Oct 2026filed 13 Oct 2026 |
| Emily M. LeproustChief Executive Officer | sold | 1,840at $200.44 | 5 Oct 2026filed 7 Oct 2026 |
| Emily M. LeproustChief Executive Officer | sold | 481at $201.26 | 5 Oct 2026filed 7 Oct 2026 |
| Emily M. LeproustChief Executive Officer | sold | 1,017at $202.32 | 5 Oct 2026filed 7 Oct 2026 |
| Emily M. LeproustChief Executive Officer | sold | 432at $203.61 | 5 Oct 2026filed 7 Oct 2026 |
| Emily M. LeproustChief Executive Officer | sold | 290at $204.80 | 5 Oct 2026filed 7 Oct 2026 |
| Emily M. LeproustChief Executive Officer | sold | 297at $205.78 | 5 Oct 2026filed 7 Oct 2026 |
| Emily M. LeproustChief Executive Officer | sold | 146at $206.84 | 5 Oct 2026filed 7 Oct 2026 |
| Emily M. LeproustChief Executive Officer | sold | 45at $207.46 | 5 Oct 2026filed 7 Oct 2026 |
| Dennis ChoOfficer | sold | 9,514at $188.88 | 2 Oct 2026filed 5 Oct 2026 |
| Patrick John FinnPresident and COO | sold | 25,714at $188.88 | 2 Oct 2026filed 5 Oct 2026 |
| Paula GreenSVP of Human Resources | sold | 10,088at $188.88 | 2 Oct 2026filed 5 Oct 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| BlackRock, Inc.added · filed 7 Aug 2026 | 5,833,891$600.2M | +279,529+5.0% |
| Artisan Partners Limited Partnershipreduced · filed 13 Aug 2026 | 4,802,017$494.0M | -1,565,760−24.6% |
| FMR LLCadded · filed 13 Aug 2026 | 4,703,044$483.8M | +2,813,099+148.8% |
| ARK Investment Management LLCreduced · filed 14 Aug 2026 | 4,549,803$468.1M | -1,792,930−28.3% |
| STATE STREET CORPreduced · filed 7 Aug 2026 | 3,232,532$332.6M | -438,150−11.9% |
| VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 2026 | 2,824,989$290.6M | +175,888+6.6% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 2,699,280$277.7M | +60,236+2.3% |
| EdgePoint Investment Group Inc.reduced · filed 14 Aug 2026 | 2,521,635$259.4M | -2,860,886−53.2% |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLCreduced · filed 12 Aug 2026 | 2,174,594$223.7M | -3,095,124−58.7% |
| FARALLON CAPITAL MANAGEMENT, L.L.C.added · filed 14 Aug 2026 | 2,136,400$219.8M | +708,750+49.6% |
News
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.